LBO France
Key facts
Recent exits
Coverage notes
5 funds tracked, 98 portfolio companies (57 active · 41 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
88 companiesFunds & portfolio
Every fund LBO France has raised, with its portfolio companies. Hand-checked from public filings.
Joliba Capital FundGrowth2023 · 3yr€33M6 active
Unrealized
6 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Industrials | Other | 2021 | |
| Telecom | Other | 2022 | |
| Business Services | Other | 2024 | |
| Telecom | Other | 2020 | |
| Business Services | Other | 2021 | |
| TMT | Other | 2024 |
LBO France Small CapBuyout2020 · 6yr€200M12 active · 12 realized
Unrealized
12 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Business Services |  France | 2021 | |
| Consumer | France | 2022 | |
| Healthcare | France | 2020 | |
| TMT | France | 2024 | |
| Industrials | France | 2024 | |
| Healthcare | France | 2025 | |
| Consumer | France | 2022 | |
| Financials | France | 2024 | |
| Business Services | France | 2023 | |
| Consumer | France | 2021 | |
| Consumer | France | 2024 | |
| Hospitality | France | 2022 |
France· Entry 2021France· Entry 2022France· Entry 2020France· Entry 2024France· Entry 2024France· Entry 2025France· Entry 2022France· Entry 2024France· Entry 2023France· Entry 2021France· Entry 2024France· Entry 2022Realized
12 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Healthcare | France | 2018 | 2023 | Trade Sale | – | ||
| Aerospace & Defence | France | 2018 | 2022 | Secondary | – | ||
| Healthcare | France | 2020 | 2026 | Trade Sale | – | ||
| MedTech | France | 2015 | 2020 | Trade Sale | – | ||
| Industrials | France | 2017 | 2025 | Trade Sale | – | ||
| TMT | France | 2019 | 2023 | Trade Sale | – | ||
| TMT | France | 2019 | 2023 | Secondary | – | ||
| Consumer | France | 2019 | 2025 | Trade Sale | – | ||
| Business Services | France | 2019 | 2025 | Secondary | – | ||
| Business Services | France | 2017 | 2021 | Secondary | – | ||
| Industrials | France | 2020 | 2025 | Secondary | – | ||
| MedTech | France | 2017 | 2022 | Trade Sale | – |
LBO France ItalyBuyout2018 · 8yr€100M4 active · 4 realized
Unrealized
4 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Consumer |  Italy | 2025 | |
| Healthcare | Italy | 2022 | |
| Healthcare | Italy | 2020 | |
| Industrials | Italy | 2018 |
Italy· Entry 2025Italy· Entry 2022Italy· Entry 2020Italy· Entry 2018Realized
4 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Consumer | Italy | 2014 | 2022 | Secondary | – | ||
| Industrials | Italy | 2012 | 2015 | Trade Sale | – | ||
| Industrials | Italy | 2017 | 2021 | Trade Sale | – | ||
| Industrials | Italy | 2019 | 2025 | Secondary | – |
LBO France VentureVC2016 · 10yr€225M20 active · 12 realized
Unrealized
20 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| TMT | France | 2025 | |
| HealthTech |  UK | 2025 | |
| MedTech | France | 2017 | |
| Healthcare | France | 2024 | |
| MedTech | France | 2022 | |
| TMT | France | 2022 | |
| HealthTech | France | 2022 | |
| HealthTech | UK | 2015 | |
| HealthTech | France | 2016 | |
| HealthTech |  Germany | 2025 | |
| Healthcare | France | 2020 | |
| MedTech | France | 2019 | |
| TMT | France | 2025 | |
| Healthcare | France | 2022 | |
| Healthcare |  Spain | 2022 | |
| TMT | France | 2022 | |
| HealthTech | France | 2019 | |
| Healthcare | France | 2023 | |
| Industrials | Italy | 2017 | |
| MedTech | France | 2015 |
France· Entry 2025UK· Entry 2025France· Entry 2017France· Entry 2024France· Entry 2022France· Entry 2022France· Entry 2022UK· Entry 2015France· Entry 2016Germany· Entry 2025France· Entry 2020France· Entry 2019France· Entry 2025France· Entry 2022Spain· Entry 2022France· Entry 2022France· Entry 2019France· Entry 2023Italy· Entry 2017France· Entry 2015Realized
12 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| MedTech | France | 2016 | 2023 | Trade Sale | – | ||
| TMT | France | 2018 | 2023 | Trade Sale | – | ||
| Business Services | France | 2016 | 2020 | Trade Sale | – | ||
| MedTech | France | 2017 | 2019 | – | – | – | |
| TMT | France | 2016 | 2021 | Trade Sale | – | ||
| HealthTech | France | 2017 | 2024 | Trade Sale | – | ||
| TMT | France | 2020 | 2025 | Secondary | – | ||
| HealthTech | France | 2017 | 2022 | Trade Sale | – | ||
| Deep Tech | France | 2017 | 2023 | MBO | – | ||
| Biotech | France | 2018 | 2025 | Trade Sale | – | ||
| HealthTech | France | 2014 | 2021 | Trade Sale | – | ||
| TMT | France | 2020 | 2022 | Secondary | – |
France· Entry 2017LBO France Mid CapBuyout2015 · 11yr€1.0B5 active · 13 realized
Unrealized
5 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| TMT | France | 2019 | |
| Consumer | France | 2017 | |
| Business Services | France | 2018 | |
| Consumer | France | 2019 | |
| Industrials | France | 2017 |
France· Entry 2019France· Entry 2017France· Entry 2018France· Entry 2019France· Entry 2017Realized
13 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Aerospace & Defence | France | 2013 | 2015 | Secondary | – | ||
| Consumer | France | 2008 | 2015 | Secondary | – | ||
| Industrials | France | 2018 | 2025 | Trade Sale | – | ||
| Construction | France | 2014 | 2017 | Trade Sale | – | ||
| Industrials | France | 2011 | 2016 | Secondary | – | ||
| Business Services | France | 2012 | 2016 | Secondary | – | ||
| Consumer | France | 2011 | 2018 | Trade Sale | – | ||
| Industrials | France | 2019 | 2026 | Trade Sale | – | ||
| Business Services | France | 2010 | 2015 | Secondary | – | ||
| Consumer | France | 2013 | 2019 | – | – | – | |
| Consumer | France | 2010 | 2016 | Trade Sale | – | ||
| Hospitality | France | 2011 | 2018 | Secondary | – | ||
| Consumer | France | 2011 | 2019 | Trade Sale | – |
France· Entry 2013Saved GPs appear in your watchlist, one click from your workspace.
About LBO France
LBO France is a French mid-market private equity firm with €2.5 billion of assets under management as of December 2024, headquartered in Paris. The firm has built a multi-decade track record across successive flagship buyout fund vintages, focusing on French and selectively European mid-cap LBO transactions with emphasis on operational value creation and management team partnership.
Investment thesis
LBO France targets French and selectively European mid-cap LBO transactions with equity ticket sizes typically ranging from €30 million to €150 million per transaction, focusing on profitable companies with €50 million to €500 million in enterprise value. Sector focus spans TMT, Business Services, Industrials, Consumer, Healthcare and Financials, with operational improvement initiatives and selective bolt-on M&A strategies driving value creation across the holding period.
Recent activity
Recent realised exits include Dutscher (healthcare, 2026), HMY (industrials, 2025), Hosman (TMT, 2025), Payot (consumer, 2025) and Prenax (business services, 2025), reflecting strong 2025-2026 distribution momentum across the platform. LBO France tracks 6 funds, 49 active portfolio companies and 39 realised exits across the multi-decade track record. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
Get the full picture on LBO France.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in